NCT01902472View on ClinicalTrials.gov

A Prospective, Observational Study of Individuals Who Seroconvert While Taking Truvada® for Pre-Exposure Prophylaxis (PrEP)

CompletedOBSERVATIONAL

Enrollment

172

Participants

Timeline

Start Date

September 2, 2013

Primary Completion Date

October 30, 2017

Study Completion Date

October 30, 2017

Conditions

HIV

Trial Locations (1)

94404

Gilead Sciences, Inc., Foster City

Sponsors

Lead Sponsor

Gilead Sciences

All Listed Sponsors

lead

Gilead Sciences

INDUSTRY